Search results
FDA panel rejects MDMA-assisted therapies for PTSD despite high hopes from veterans
Fox News via Yahoo News· 2 days agoAn FDA panel rejected MDMA-based treatments for PTSD often used with veterans. One advocate shared...
The FDA Should Reject MDMA Therapy—but Not for the Reasons You Think
Slate via Yahoo News· 2 days agoThis may lead participants to think that distress is healing—even if it’s actually causing harm....
Why FDA Panel Rejected MDMA Therapy—And What’s Next For Psychedelic Medicine
Forbes· 2 days agoHigh hopes that psychedelic medicines were finally on the pathway to regulation were dashed last...
FDA rejects promising new therapy for PTSD, veteran advocates sound off: ‘Big gut punch’
BizPac Review· 2 days agoA Federal Drug Administration advisory panel has voted against authorizing MDMA-assisted therapy for PTSD. MDMA, more ...
FDA advisers vote against first MDMA therapy to treat PTSD
News Channel Nebraska· 6 days agoBy Deidre McPhillips, CNN
MDMA-maker failed its FDA hearing — and its PTSD patients
The Eagle-Tribune· 7 days agoThis week, the Food and Drug Administration’s expert advisers sent a strong message that Lykos...
With MDMA debate spreading beyond biotech, Lykos CEO tries to dispel efficacy, safety concerns
FierceBiotech· 2 days agoA week after an FDA committee declined to support an midomafetamine (MDMA) treatment for...
MDMA’s Future As A Treatment For PTSD Is In Question
Inverse· 4 days agoWhile the FDA will still vote separately on MDMA, it generally follows the recommendation of its advisors, so its unlikely the novel treatment will gain approval. The drug ...
Trouble for ecstasy? What MDMA’s FDA setback could mean for psychedelics
NPR· 2 days agoGeneral Hospital, who presented on behalf of Lykos about the need for more PTSD treatment. Gorman acknowledges the Lykos' therapy protocol is more “open-ended ...
Psychedelics Stocks Are Falling After a Shocking Vote at the FDA. Here's What You Need to Know.
Motley Fool via Yahoo Finance· 5 days agoThe second question was whether the intervention is worth the risk to patients; the vote was 10-1....